Market Overview:
The global Reduced Serum Medium market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The other type segment is expected to be the fastest-growing segment during the forecast period. This can be attributed to the increasing demand for reduced serum mediums that are non-phenol red based, owing to their low toxicity and better performance characteristics as compared with phenol red based reduced serum media. In terms of application, cell culture is expected to hold the largest share of the global Reduced Serum Medium market in 2018.
Product Definition:
A serum-free culture medium is a type of cell culture medium that does not contain any serum proteins. Serum proteins are necessary for the growth and survival of cells in culture, so eliminating them from the media environment results in a reduction in cell proliferation and viability. Reduced serum media are used to study the effects of reduced protein levels on cellular function. They can also be used to screen for drugs or other compounds that improve or impair cell growth in the absence of serum proteins.
L-glutamine Type:
L-glutamine is a nonessential amino acid. It is the most abundant amino acid found in the human body and plays an important role in maintaining optimal health. L-glutamine can be naturally produced by the body from certain foods including meat, seafood, and dairy products. However, it can also be synthesized by chemical synthesis using various raw materials such as dextrose or sugarcane.
Phenol Red Type:
Phenol red is a colorless solution containing 6% phenol. It is used as a indicator for measuring the concentration of reduced (reduced) serum in biological fluids such as blood and urine. The solutions are prepared by mixing 6% phenol with 96% saline solution, which upon addition to body fluids will turn into a deep red color due to the presence of ferrous ion.
Application Insights:
The other application segment includes biopharmaceuticals, clinical trials and diagnosticostics. The cell culture application segment is expected to witness the fastest growth over the forecast period owing to its rising use in various research studies. It has been observed that reduced serum medium helps maintain cell cultures which are essential for drug development and other processes including toxicology testing in biotechnology companies.
Clinical trials are also expected to grow at a significant rate during the forecast period due to its increasing use in preclinical safety evaluation of new drugs as well as vaccines. In addition, it is used extensively for monitoring disease progression and identifying factors responsible for mortality & morbidity associated with diseases such as cancer & AIDS during clinical trials which may eventually help develop better treatment options leading to improved patient outcomes globally reducing mortality & morbidity associated with these diseases eventually driving growth of this market over the forecast period.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance during the forecast period owing to high R&D investments and technological advancements in biotechnology & pharmaceutical industries. In addition, presence of major players and well-established healthcare infrastructure are some other factors contributing toward growth of this regional market.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period due to rising number of clinical trials being conducted across emerging countries such as China & India. Moreover, increasing disposable income levels coupled with rise in consumer awareness regarding advanced treatment options will drive regional market growth during the estimated time span from 2018 to 2030 (USD Million).
In addition, government initiatives encouraging medical tourism especially for cancer treatments are expected boost demand for reduced serum medium products across Asia Pacific region thereby driving overall global market growth over the projected period from 2018 To 2030 (USD Million).
Growth Factors:
- Increasing demand for Reduced Serum Medium from biotechnology and pharmaceutical companies for drug discovery and development processes.
- Growing number of research institutes and universities that are using Reduced Serum Medium for various research applications.
- Rising awareness about the benefits of Reduced Serum Medium among researchers, scientists, and laboratory personnel.
Scope Of The Report
Report Attributes
Report Details
Report Title
Reduced Serum Medium Market Research Report
By Type
L-glutamine Type, Phenol Red Type, Other
By Application
Cell Culture, Other
By Companies
Lonza Bioscience, Thermo Fisher Scientific, Corning, Merck, Cytiva, HiMedia
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Reduced Serum Medium Market Report Segments:
The global Reduced Serum Medium market is segmented on the basis of:
Types
L-glutamine Type, Phenol Red Type, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell Culture, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza Bioscience
- Thermo Fisher Scientific
- Corning
- Merck
- Cytiva
- HiMedia
Highlights of The Reduced Serum Medium Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- L-glutamine Type
- Phenol Red Type
- Other
- By Application:
- Cell Culture
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Reduced Serum Medium Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Reduced Serum Medium is a sterile solution that is used to culture cells and tissues. It contains low levels of oxygen, which helps preserve the cells and tissues.
Some of the major companies in the reduced serum medium market are Lonza Bioscience, Thermo Fisher Scientific, Corning, Merck, Cytiva, HiMedia.
The reduced serum medium market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Reduced Serum Medium Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Reduced Serum Medium Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Reduced Serum Medium Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Reduced Serum Medium Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Reduced Serum Medium Market Size & Forecast, 2020-2028
4.5.1 Reduced Serum Medium Market Size and Y-o-Y Growth
4.5.2 Reduced Serum Medium Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 L-glutamine Type
5.2.2 Phenol Red Type
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cell Culture
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Reduced Serum Medium Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Reduced Serum Medium Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 L-glutamine Type
9.6.2 Phenol Red Type
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cell Culture
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 L-glutamine Type
10.6.2 Phenol Red Type
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cell Culture
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 L-glutamine Type
11.6.2 Phenol Red Type
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cell Culture
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 L-glutamine Type
12.6.2 Phenol Red Type
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cell Culture
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 L-glutamine Type
13.6.2 Phenol Red Type
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cell Culture
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Reduced Serum Medium Market: Competitive Dashboard
14.2 Global Reduced Serum Medium Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Lonza Bioscience
14.3.2 Thermo Fisher Scientific
14.3.3 Corning
14.3.4 Merck
14.3.5 Cytiva
14.3.6 HiMedia
